These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Celiac disease and diffuse T-cell lymphoma of the colon. Pulte D; Murray J Gastrointest Endosc; 2001 Mar; 53(3):379-81. PubMed ID: 11231410 [No Abstract] [Full Text] [Related]
9. The value of small bowel magnetic resonance imaging in the management of enteropathy associated T-cell lymphoma. Laird J; Leach M; Ballantyne S Br J Haematol; 2008 Jul; 142(1):136-7. PubMed ID: 18477052 [No Abstract] [Full Text] [Related]
10. Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma. Schmitz N; Kloess M; Reiser M; Berdel WE; Metzner B; Dorken B; Kneba M; Trumper L; Loeffler M; Pfreundschuh M; Glass B; Cancer; 2006 Jan; 106(1):136-45. PubMed ID: 16331635 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-associated T-cell lymphoma of the maxillary sinus in a renal transplant recipient. Shiong YS; Lian JD; Lin CY; Shu KH; Lu YS; Chou G Transplant Proc; 1992 Oct; 24(5):1929-31. PubMed ID: 1329289 [No Abstract] [Full Text] [Related]
12. Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma. Derenzini E; Casadei B; Broccoli A; Gandolfi L; Pellegrini C; Zinzani PL Br J Haematol; 2014 Aug; 166(4):625-8. PubMed ID: 24750128 [No Abstract] [Full Text] [Related]